Clinical Trials on MDR TB in New Zealand
Total 112 results
-
GlaxoSmithKlineCompletedDepressive Disorder, Major | Major Depressive Disorder (MDD)United States
-
Actinogen MedicalAXIOM Real Time MetricsActive, not recruitingCognitive Impairment | Major Depressive Disorder | MDDAustralia, United Kingdom
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
GlaxoSmithKlineCompletedDepressive Disorder, Major | Major Depressive Disorder (MDD)United States
-
AstraZenecaTargacept Inc.CompletedDepression | Major Depressive Disorder | MDDUnited States, Puerto Rico
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Anemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndromes (MDS) | Chronic Myelomonocytic Leukemia (CMML) | Low to Intermediate-1 MDSUnited States, France
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDsFrance, Germany, Hungary, Canada, Australia, Austria, Czech Republic, Switzerland
-
Heinrich-Heine University, DuesseldorfTerminatedMyelodysplastic Syndrome MDSGermany
-
Fred Hutchinson Cancer CenterPatient-Centered Outcomes Research Institute; American Cancer Society, Inc.CompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
NovartisCompletedMajor Depressive Disorder (MDD)United States
-
Seattle Children's HospitalChildren's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...CompletedAML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDSUnited States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)Finland, Germany, Korea, Republic of, United States, Taiwan, Estonia, India, Italy, Mexico
-
medac GmbHSynteract, Inc.RecruitingMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML) | Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)United States
-
GlaxoSmithKlineCompleted
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Assurex Health Inc.University of MichiganCompletedMajor Depressive Disorder (MDD)United States
-
Eli Lilly and CompanyCompletedMajor Depressive Disorder (MDD)United States, Puerto Rico, Finland, Japan, Slovakia, Czechia, Croatia
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
NexImmune Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Tragara Pharmaceuticals, Inc.CompletedMultiple Myeloma | AML | Blast Crisis | MDS | ALLUnited States
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Opna-IO LLCCompletedHigh-risk Myelodysplastic Syndrome (MDS) | Relapsed Acute Myeloid Leukemia (AML) | Refractory Acute Myeloid Leukemia (AML)United States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)United States, Australia, France, Spain
-
OncoTherapy Science, Inc.TerminatedAML | Advanced MDS | ALL | Advanced CML | Advanced MPNsUnited States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
-
Cullinan Oncology Inc.RecruitingMyelodysplastic Syndrome (MDS) | Relapsed/Refractory Acute Myeloid Leukemia (AML)United States
-
Queensland Centre for Gynaecological CancerGlaxoSmithKline Research & Development LimitedNot yet recruitingMmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial AdenocarcinomaAustralia
-
Jazz PharmaceuticalsWithdrawnAcute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS)United States
-
CelgeneRecruitingBeta-thalassemia | Myelodysplastic Syndromes (MDS) | Myeloproliferative Neoplasm(MPN)-Associated MyelofibrosisUnited States, Japan, Israel, United Kingdom, Turkey, Greece, France, Australia, Belgium, Bulgaria, Canada, Germany, Italy, Malaysia, Spain, Sweden, Taiwan, Thailand, Tunisia, China, Lebanon, Netherlands
-
Treadwell Therapeutics, IncRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | AML | MDS | CMMLHong Kong, United States, Canada
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, Hungary
-
Ocuphire Pharma, Inc.CompletedDiabetic Retinopathy | Diabetic Macular Edema | NPDR - Non Proliferative Diabetic Retinopathy | PDR - Proliferative Diabetic RetinopathyUnited States
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
Diane GeorgeRecruitingAcute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Chronic Myeloid Leukemia (CML) | Juvenile Myelomonocytic Leukemia (JMML) | Lymphoma (Hodgkin's and Non-Hodgkin's)United States
-
AmgenRecruitingB-precursor Acute Lymphoblastic LeukemiaUnited States
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
TetraLogic PharmaceuticalsTerminatedChronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States, Spain, Australia, Germany
-
Memorial Sloan Kettering Cancer CenterPediatric Brain Tumor ConsortiumTerminatedFanconi Anemia | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML)United States
-
Onconova Therapeutics, Inc.The Leukemia and Lymphoma SocietyCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | MDS | RAEBUnited States, Belgium, Germany, Spain, France, Italy
-
AbbVieAbbVieEnrolling by invitationDiabetic Retinopathy, DRUnited States
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Children's Hospital Medical Center, CincinnatiMemorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer CenterRecruitingFanconi Anemia | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Severe Marrow FailureUnited States
-
AbbVieTerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Australia, Germany, Israel, Italy, Japan, Spain
-
Gamida Cell ltdCompletedTransplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HMHematological Malignancies | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS)United States, Singapore, Spain, Netherlands, Italy
-
Therapeutic Advances in Childhood Leukemia ConsortiumRecruitingLymphoma, B-Cell | Hodgkin Lymphoma | Lymphoblastic Lymphoma | Lymphoma, T-Cell | AML | Hematologic Malignancy | MDS | Acute Undifferentiated Leukemia | ALL | Mixed Phenotype Acute Leukemia | BPDCNUnited States, Australia
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden